EUCTR2005-001341-42-DKActive, not recruitingPhase 1
Treatment strategy in adrenocortical carcinomasFase II trial with docetaxel and cisplatin in patients with locally advanced or disseminated adrenocortical carcinomas
Drugs
Trial Snapshot
- Phase
- Phase 1
- Status
- Active, not recruiting
- Sponsor
- Rigshospitalet
- Enrollment
- 39
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional clinical trial of medicinal product
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •Adrenocortical carcinoma
- •no possibility for operation
- •age > 18 years
- •performance 0 or 1
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
Exclusion Criteria
- •performance 2 or less
- •other cancer diseases
Investigators
Similar Trials
Active, not recruiting
Not Applicable
Optimal Methods of Disease Progression and Survival Analysis in Children and Adults Patients With Adrenocortical Cancer (ACC)Adrenocortical CarcinomaNCT04358107National Cancer Institute (NCI)1,000
Completed
Not Applicable
Retrospective audit of adrenocortical carcinomas treated at Tata Memorial Hospital.CTRI/2016/04/006894ot applicable30
Completed
Phase 2
Surgery and Heated Chemotherapy for Adrenocortical CarcinomaPeritoneal CarcinomatosisAdrenocortical CarcinomaNCT01833832National Cancer Institute (NCI)11
Active, not recruiting
Not Applicable
Preclinical Study Towards an Immunotherapy in Adrenocortical CarcinomaCushing's SyndromeAdrenocortical CarcinomaNCT00457587University of Wuerzburg150
Unknown
Phase 2
Cabazitaxel Activity in Patients With Advanced AdrenoCortical-Carcinoma Progressing After Previous Chemotherapy LinesAdrenocortical CarcinomaNCT03257891Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia25